Screener
Bioventus BVS International Segment — Total Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Bioventus’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:43 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001665988-26-000042
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|---|---|
| Net sales | $153,208 | $147,660 | $285,297 | $271,536 |
| Cost of sales (including depreciation and amortization of $9,893, $10,603, $19,980 and $20,868, respectively) | 47,542 | 45,570 | 88,862 | 86,390 |
| Gross profit | 105,666 | 102,090 | 196,435 | 185,146 |
| Selling, general and administrative expense | 82,740 | 79,110 | 161,065 | 152,612 |
| Research and development expense | 3,173 | 3,172 | 5,640 | 6,183 |
| Restructuring costs | (415) | — | 39 | — |
| Depreciation and amortization | 1,041 | 1,439 | 2,148 | 3,032 |
| Loss on disposals | — | 1 | — | 82 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bioventus's international segment — total net sales?
- Bioventus (BVS) reported international segment — total net sales of $18.74M in Q2 2026.
- How has Bioventus's international segment — total net sales changed year-over-year?
- Bioventus's international segment — total net sales decreased by 0.8% year-over-year, from $18.89M to $18.74M.
- What is the long-term trend for Bioventus's international segment — total net sales?
- Over 3 years (2022 to 2025), Bioventus's international segment — total net sales has grown at a 5.1% compound annual growth rate (CAGR), from $56.87M to $65.99M.
- What does international segment — total net sales mean?
- Represents the total revenue generated from the sale of medical technology products and services within international markets. This metric reflects the company's global market penetration and the demand for its orthopedic and surgical solutions outside of its primary domestic region.
Ask your AI about Bioventus's international segment — total net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude